3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Neoplasms
12
Breast Neoplasms
7
Neoplasm Metastasis
5
Lymphoma
5
Multiple Myeloma
4
Leukemia
4
Hematologic Neoplasms
4
Colorectal Neoplasms
4
Prostatic Neoplasms
3
Lung Neoplasms
3
Leukemia, Myeloid, Acute
3
Depression
3
Urinary Bladder Neoplasms
2
Triple Negative Breast Neoplasms
2
Ovarian Neoplasms
2
Motor Activity
2
Malignant Female Reproductive System Neoplasm
2
Glioblastoma
2
Fatigue
2
Fallopian Tube Neoplasms
2
Endometrial Neoplasms
2
Caregiver Burden
2
Anxiety Disorders
2
Advanced Malignant Solid Neoplasm
2
Thyroid Neoplasms
1
Stroke
1
Stress Disorders, Post-Traumatic
1
Squamous Cell Carcinoma of Head and Neck
1
Sleep Initiation and Maintenance Disorders
1
Signs and Symptoms
1
Interventions
Vitamin D
1
Synbiotics
1
Prebiotics
1
Palliative Care
1
Magnetic Resonance Spectroscopy
1
Functional Status
1
Cognitive Training
1
Acetylcysteine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Chemotherapy-Related Cognitive Impairment
×
Palliative Care
×
1 year
×
Clear all
NCT04586530
2026-01-21
TAMS
University of Pittsburgh
Phase NA
Active not recruiting
220 enrolled